Literature DB >> 17447706

Snakes of medical importance in India: is the concept of the "Big 4" still relevant and useful?

Ian D Simpson1, Robert L Norris.   

Abstract

Snakebites continue to be a major medical concern in India. However, there is very little hard evidence of a numerical nature to enable us to understand which species are responsible for mortality and morbidity. For many decades, the concept of the "Big 4" Snakes of Medical Importance has reflected the view that 4 species are responsible for Indian snakebite mortality--the Indian cobra (Naja naja), the common krait (Bungarus caeruleus), the Russell's viper (Daboia russelii) and the saw-scaled viper (Echis carinatus). However, a recent discovery that another species, the hump-nosed pit viper (Hypnale hypnale), is capable of causing lethal envenomation, and that this problem was being concealed by systematic misidentification of this species as the saw-scaled viper, has necessitated a review of the concept of the "Big 4." The concept of the "Big 4" snakes is reviewed to demonstrate its failure to include all currently known snakes of medical significance in India, and its negative effects related to clinical management of snakebite. The emergence of the hump-nosed pit viper (Hypnale hypnale) as a snake of medical significance has rendered the "Big 4" obsolete in terms of completeness. The concept of the "Big 4" is restricting sound epidemiological work and the development of effective snake antivenoms. It should be replaced by the model introduced in the 1980s by the World Health Organization, which has not received adequate circulation and implementation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17447706     DOI: 10.1580/06-weme-co-023r1.1

Source DB:  PubMed          Journal:  Wilderness Environ Med        ISSN: 1080-6032            Impact factor:   1.518


  37 in total

Review 1.  Mast Cells and IgE can Enhance Survival During Innate and Acquired Host Responses to Venoms.

Authors:  Stephen J Galli; Philipp Starkl; Thomas Marichal; Mindy Tsai
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

2.  A study on the clinico-epidemiological profile and the outcome of snake bite victims in a tertiary care centre in southern India.

Authors:  Halesha B R; Harshavardhan L; Lokesh A J; Channaveerappa P K; Venkatesh K B
Journal:  J Clin Diagn Res       Date:  2012-09-14

3.  Effectiveness of rapid transport of victims and community health education on snake bite fatalities in rural Nepal.

Authors:  Sanjib K Sharma; Patrick Bovier; Nilambar Jha; Emilie Alirol; Louis Loutan; François Chappuis
Journal:  Am J Trop Med Hyg       Date:  2013-04-08       Impact factor: 2.345

4.  Mast cells and IgE in defense against lethality of venoms: Possible "benefit" of allergy[].

Authors:  Stephen J Galli; Martin Metz; Philipp Starkl; Thomas Marichal; Mindy Tsai
Journal:  Allergo J Int       Date:  2020-03-02

5.  Inadequacy of present polyspecific anti snakevenom - a study from central Kerala.

Authors:  Veerendra Kumar; P Sabitha
Journal:  Indian J Pediatr       Date:  2011-03-03       Impact factor: 1.967

6.  Local and systemic toxicity of Echis carinatus venom: neutralization by Cassia auriculata L. leaf methanol extract.

Authors:  A N Nanjaraj Urs; M Yariswamy; Vikram Joshi; K N Suvilesh; M S Sumanth; Diganta Das; A Nataraju; B S Vishwanath
Journal:  J Nat Med       Date:  2014-11-07       Impact factor: 2.343

7.  Emergency treatment of a snake bite: Pearls from literature.

Authors:  Syed Moied Ahmed; Mohib Ahmed; Abu Nadeem; Jyotsna Mahajan; Adarash Choudhary; Jyotishka Pal
Journal:  J Emerg Trauma Shock       Date:  2008-07

Review 8.  Snake bite in South Asia: a review.

Authors:  Emilie Alirol; Sanjib Kumar Sharma; Himmatrao Saluba Bawaskar; Ulrich Kuch; François Chappuis
Journal:  PLoS Negl Trop Dis       Date:  2010-01-26

Review 9.  The Mast Cell-IgE Paradox: From Homeostasis to Anaphylaxis.

Authors:  Stephen J Galli
Journal:  Am J Pathol       Date:  2016-02       Impact factor: 4.307

10.  IgE antibodies, FcεRIα, and IgE-mediated local anaphylaxis can limit snake venom toxicity.

Authors:  Philipp Starkl; Thomas Marichal; Nicolas Gaudenzio; Laurent Lionel Reber; Riccardo Sibilano; Mindy Tsai; Stephen Joseph Galli
Journal:  J Allergy Clin Immunol       Date:  2015-09-26       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.